Rhythm Pharmaceuticals (RYTM) - Dividend History and Outstanding Shares
Currently (November 2024) RYTM does not pay dividends. Last Dividend paid: . Outstanding Shares Growth Rate 100.00%
No Dividends
As of November 2024, Rhythm Pharmaceuticals (RYTM) does not pay a dividend.
As of November 2024, Rhythm Pharmaceuticals (RYTM) does not pay a dividend.
Outstanding Shares
What is the Trend of RYTM`s Outstanding Shares?
The Outstanding Shares of Rhythm Pharmaceuticals are growing at a rate of 19.82% per year on average over the last 10 years. The Correlation Coefficent of the Outstanding Shares is 100.00%. Investors should be aware that the price of a stock often is negatively affected by an increasing number of shares.Did Rhythm Pharmaceuticals ever had a Stock Split?
No Stock Splits found.| Year | Number of Shares (Mill.) | Growth |
|---|---|---|
| 2024 | 61.01 | +3.04% |
| 2023 | 59.21 | +5.17% |
| 2022 | 56.3 | +11.99% |
| 2021 | 50.27 | +13.69% |
| 2020 | 44.22 | +4.75% |
| 2019 | 42.21 | +22.71% |
| 2018 | 34.4 | +31.43% |
| 2017 | 26.17 | +56.46% |
| 2016 | 16.73 | +67.3% |
| 2015 | 10 |
Dividend Yields, Growth & Consistency
| Overall Dividend Rating | - | ||
| Dividends Paid 12m | - | Yield 12m | - |
| Payout Consistency | - | Yield on Cost 5y | - |
| Growth Rate 5y | - | Correlation Rate 5y | - |
| First Payout | - | Next Payout | - |
| Compare RYTM Dividends with its Industry Peers | |||
No Dividends Paid
-- RYTM`s 0.00% Dividend Yield is calculated by dividing the dividend payments of the last 12-Months (TTM) of 0.00 by the current stock price 56.25.
- 0.00% Yield on Cost is the effective dividend income you'd receive today if you purchased the stock five years ago (Rate of the last 12 Months 0.00 divided by the price 5 years ago).
- The 0.0% Payout Consistency of RYTM Dividends gauges Stability (Values above 80%) or Fragility (Values under 60%).
- The Average Dividend Growth Rate of 0.00% per year in the last 5-Years showcases RYTM`s commitment to shareholders. Steady or increasing dividends over time can be a sign of a healthy financial outlook.
Ratings surpassing 50 are regarded as favorable, while those exceeding 75 are exceptionally strong. The calculations includes: Yield, Yield on Cost, Consistency of Payouts and Growth Rates over time.